• Share
  • Email
  • Print

Michael D. Bryan

Partner
+1.843.579.5661
Fax +1.843.579.8801
+1.214.939.5747
Fax +1.214.939.5849
Mike Bryan is a partner in the Charleston and Dallas offices and focuses his practice on corporate and securities law, mergers and acquisitions, and finance. He regularly advises clients on matters related to corporate governance, securities law compliance and reporting requirements, stock exchange rules, executive compensation, boards of directors, and compliance. He handles a wide variety of transactions, including acquisitions, divestitures, joint ventures, licensing, and debt and equity offerings. He advises clients in the agricultural and industrial biotechnology, manufacturing, retail, and healthcare industries.

Professional Background

Prior to joining the firm, Mr. Bryan was a partner in the Charleston office of a regional firm and prior to that was Associate General Counsel at a global agricultural biotechnology company.

Professional/Civic Activities

  • American Bar Association
  • Society of Corporate Secretaries and Governance Professionals
  • Charleston County Bar Association
  • Council for Entrepreneurial Development
  • South Carolina Biomass Council
  • Represented an agricultural biotechnology company in its $760 million initial public offering
  • Represented a private company that is a leading developer of biotechnology-improved trees in its $70 million acquisition of three nursery and tree development businesses in the United States, New Zealand and Australia
  • Represented a public agricultural biotechnology company in its $1.4 billion acquisition of a global seed business with operations in 29 countries
  • Represented a public agricultural biotechnology company in the spinoff of its chemical business with a market capitalization of $3 billion
  • Represented a public agricultural biotechnology company in its $435 million acquisition of a biotechnology and pharmaceutical research campus from a public pharmaceutical company
  • Represented a private equity investor in its $604 million acquisition of a life insurance company
  • Represented a public company in connection with a Government Accounting Office investigation related to product pricing in the United States and Argentina
  • Represented a nonprofit hospital system in connection with multiple bond financings totalling over $400 million
  • Represented a public company in its $2.5 billion leveraged recapitalization involving a $1.1 billion note offering and a self-tender offer
  • Represented a public company in its $140 million divestiture of its retail sales and finance businesses
  • Represented a public company in its $60 million acquisition of an industrial manufacturing business
  • Represented a public company in its $85 million acquisition of a vitamin and supplement manufacturing business
  • Represented a public company in its $157 million divestiture of an industrial division